Regarding CLX- isn't this just too much? It's not unusual to be CEO of other companies - yet the aquisitions timed similiar are somewhat a red flag, imho. Nobody is that effient........are they?
A major focus of the first newsletter issues will be the expected acquisition of Zonda, which develops and manufactures unique diagnostic tests for both the medical and non-medical markets. CLX and Zonda have executed an initial agreement in the form of a letter of intent under which CLX would acquire the remaining issued and outstanding shares of Zonda. Once the remaining due diligence is complete, the companies expect to reach a definitive agreement regarding the acquisition.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.